What is respira technologies? Respira Technologies, Inc. is a platform device and biotechnology company with a focus on aerosol science. We are creating breakthrough aerosol devices and formulations that safely deliver a broad range of pharmaceuticals and nicotine. To create novel medical devices of unparalleled efficiency.What is respiras lead program? Respira is a clinical-stage inhaled therapeutics company developing next-generation pulmonary targeted therapeutics to address significant unmet patient needs in cardio-pulmonary diseases. Our lead program is in Phase 2 clinical testing for the treatment of pulmonary arterial hypertension (PAH). LEARN MORE >What is respiras lead product candidate rt234? Our lead product candidate, RT234, is in Phase 2 clinical development for treating symptoms of pulmonary arterial hypertension (PAH). Respira combines advanced dry-powder inhaler technologies with innovative drug formulation approaches to overcome historical challenges of pulmonary drug delivery.Why invest in respira? With our first product partnered, industry-leading expertise in inhaled drug formulation and product development, and broad management experience in company-building, Respira is positioned for future success. Our lead product candidate, RT234, is in Phase 2 clinical development for treating symptoms of pulmonary arterial hypertension (PAH).
20 3422 8400 Contact. Let us help achieve your climate and social impact goals. Please contact us via email below and a member of our team will be in touch within two business days. If you need immediate assistance, please contact us on info@ respira-international.com or +44 (0) 20 3422 8400. Title:* --- Mr. Mrs. Ms. Miss.